Protein kinase biochemistry and drug discovery

被引:111
作者
Schwartz, Phillip A. [1 ]
Murray, Brion W. [1 ]
机构
[1] Pfizer Inc, Pfizer Worldwide Res & Dev, San Diego, CA 92121 USA
关键词
Protein kinase; Phosphorylation; Drug discovery; Enzyme mechanism; Irreversible inhibition; Phosphotransfer; GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; ROUS-SARCOMA-VIRUS; TYROSINE KINASE; KINETIC-MECHANISM; PHOSPHORYL-TRANSFER; TRANSITION-STATE; CATALYTIC SUBUNIT; CRYSTAL-STRUCTURE; META-PHOSPHATE;
D O I
10.1016/j.bioorg.2011.07.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein kinases are fascinating biological catalysts with a rapidly expanding knowledge base, a growing appreciation in cell regulatory control, and an ascendant role in successful therapeutic intervention. To better understand protein kinases, the molecular underpinnings of phosphoryl group transfer, protein phosphorylation, and inhibitor interactions are examined. This analysis begins with a survey of phosphate group and phosphoprotein properties which provide context to the evolutionary selection of phosphorylation as a central mechanism for biological regulation of most cellular processes. Next, the kinetic and catalytic mechanisms of protein kinases are examined with respect to model aqueous systems to define the elements of catalysis. A brief structural biology overview further delves into the molecular basis of catalysis and regulation of catalytic activity. Concomitant with a prominent role in normal physiology, protein kinases have important roles in the disease state. To facilitate effective kinase drug discovery, classic and emerging approaches for characterizing kinase inhibitors are evaluated including biochemical assay design, inhibitor mechanism of action analysis, and proper kinetic treatment of irreversible inhibitors. As the resulting protein kinase inhibitors can modulate intended and unintended targets, profiling methods are discussed which can illuminate a more complete range of an inhibitor's biological activities to enable more meaningful cellular studies and more effective clinical studies. Taken as a whole, a wealth of protein kinase biochemistry knowledge is available, yet it is clear that a substantial extent of our understanding in this field remains to be discovered which should yield many new opportunities for therapeutic intervention. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:192 / 210
页数:19
相关论文
共 236 条
[51]   Structural and mechanistic underpinnings of the differential drug sensitivity of EGFR mutations in non-small cell lung cancer [J].
Eck, Michael J. ;
Yun, Cai-Hong .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2010, 1804 (03) :559-566
[52]   ACTIVITY PHOSPHORYLATING TYROSINE IN POLYOMA T-ANTIGEN IMMUNOPRECIPITATES [J].
ECKHART, W ;
HUTCHINSON, MA ;
HUNTER, T .
CELL, 1979, 18 (04) :925-933
[53]   Too many roads not taken [J].
Edwards, Aled M. ;
Isserlin, Ruth ;
Bader, Gary D. ;
Frye, Stephen V. ;
Willson, Timothy M. ;
Yu, Frank H. .
NATURE, 2011, 470 (7333) :163-165
[54]   PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib [J].
Engelman, Jeffrey A. ;
Zejnullahu, Kreshnik ;
Gale, Christopher-Michael ;
Lifshits, Eugene ;
Gonzales, Andrea J. ;
Shimamura, Takeshi ;
Zhao, Feng ;
Vincent, Patrick W. ;
Naumov, George N. ;
Bradner, James E. ;
Althaus, Irene W. ;
Gandhi, Leena ;
Shapiro, Geoffrey I. ;
Nelson, James M. ;
Heymach, John V. ;
Meyerson, Matthew ;
Wong, Kwok-Kin ;
Janne, Pasi A. .
CANCER RESEARCH, 2007, 67 (24) :11924-11932
[55]  
ERNEUX C, 1983, J BIOL CHEM, V258, P4137
[56]   Insights into protein kinase regulation and inhibition by large scale structural comparison [J].
Eswaran, Jeyanthy ;
Knapp, Stefan .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2010, 1804 (03) :429-432
[57]   Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing [J].
Fedorov, Oleg ;
Huber, Kilian ;
Eisenreich, Andreas ;
Filippakopoulos, Panagis ;
King, Oliver ;
Bullock, Alex N. ;
Szklarczyk, Damian ;
Jensen, Lars J. ;
Fabbro, Doriano ;
Trappe, Joerg ;
Rauch, Ursula ;
Bracher, Franz ;
Knapp, Stefan .
CHEMISTRY & BIOLOGY, 2011, 18 (01) :67-76
[58]   The (un)targeted cancer kinome [J].
Fedorov, Oleg ;
Mueller, Susanne ;
Knapp, Stefan .
NATURE CHEMICAL BIOLOGY, 2010, 6 (03) :166-169
[59]  
Fersht A., 1999, STRUCTURE MECH PROTE, P54
[60]  
FISCHER EH, 1955, J BIOL CHEM, V216, P121